Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repinotan in Acute Ischemic Stroke
NCT00044915Phase 2Completed
- Sponsor
- Bayer
- Start
- Dec 2000
- Countries
- 15
01
Overview
A Phase 2 trial of repinotan in ischemic stroke, sponsored by Bayer. Started Dec 2000; status: completed.
02
Drugs
repinotan
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00044915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044915.